May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Nanoparticles Sustain Extended-release of Flt Intraceptors in the Cornea and Can Inhibit Injury-induced Corneal Angiogenesis
Author Affiliations & Notes
  • B. K. Ambati
    Medical College of Georgia, Martinez, Georgia
    Ophthalmology,
  • P. D. Jani
    Medical College of Georgia, Martinez, Georgia
    Ophthalmology,
  • N. Singh
    Medical College of Georgia, Martinez, Georgia
    Ophthalmology,
  • C. Jenkins
    Medical College of Georgia, Martinez, Georgia
    Ophthalmology,
  • S. Raghava
    Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • M. Yun
    Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • S. Sundaram
    Pharmaceutical Sciences, University of Nebraska Medical Center, Martinez, Nebraska
  • A. Mayo
    Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • R. Caldwell
    Medical College of Georgia, Martinez, Georgia
    Vascular Biology,
  • U. B. Kompella
    Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • Footnotes
    Commercial Relationships B.K. Ambati, Patent pending, P; P.D. Jani, None; N. Singh, None; C. Jenkins, None; S. Raghava, None; M. Yun, None; S. Sundaram, None; A. Mayo, None; R. Caldwell, None; U.B. Kompella, Patent Pending, P.
  • Footnotes
    Support FFS Postdoctoral Fellowship; Knights Templar; NEI R24EY017045
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3197. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. K. Ambati, P. D. Jani, N. Singh, C. Jenkins, S. Raghava, M. Yun, S. Sundaram, A. Mayo, R. Caldwell, U. B. Kompella; Nanoparticles Sustain Extended-release of Flt Intraceptors in the Cornea and Can Inhibit Injury-induced Corneal Angiogenesis. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3197. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To determine whether long-term expression of intraceptors can be achieved using plasmid-albumin nanoparticles and whether nanoparticles can inhibit and regress murine corneal neovascularization induced by mechanical-chemical trauma

Methods:: Albumin nanoparticles encapsulating pCMV.Flt23K were developed as a lyophilized product that is easily redispersed in an aqueous medium. Nanoparticles were injected into the corneas of uninjured Balb/C mice and observed for toxicity for 3 weeks. Entry of nanoparticles into corneal cells was demonstrated through transmission electron microscopy and confocal imaging. Naked pCMV.Flt23K, nanoparticles encapsulating pCMV.Flt23K, or empty pCMV nanoparticles were injected into uninjured mouse corneas. These corneas were subjected to mechanical-alkali trauma 3 weeks after injection.

Results:: Nanoparticles were non-toxic to the cornea and entered into corneal keratocyte cytoplasm. They persisted for at least 4 weeks in the cornea. Nanoparticles expressed effective intraceptor levels for at least 5 weeks and reduced corneal neovascularization by approximately 40% (p=0.035) at 5 weeks post-administration.

Conclusions:: Albumin nanoparticles are not toxic to the cornea and can express intraceptors for extended periods of time, which are effective in suppressing injury-induced corneal neovascularization.

Keywords: cornea: basic science • neovascularization • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×